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METHOD OF OPTICAL TREATMENT 
FIELD OF THE INVENTION 
2 
The natural process of emmetropization is regulated by the 
equilibrium between the above opposite defocus. Incidences 
of refractive errors are secondary to the disruption of the 
equilibrium. For example, insufficient ambient myopic defo-
cus may cause myopia. On the other hand, excessive ambient 
myopic defocus may cause hyperopia. 
The present invention relates to a method of optical treat-
ment. In particular, the present invention relates to a method 
for treating progression of refractive disorders, such as myo-
pia and hyperopia, in human eyes. 
BACKGROUND OF THE INVENTION 
The retina is the innermost layer of an eyeball and is the 
place where optical images created by the lens of the eye is 
focused. The information from the images are turned into 
nerve impulses, which are then sent to the brain via the optic 
nerve. If the retina does not coincide with the resultant focal 
point of the optical elements of the eye, defocus is generated. 
Existing optical aids and refractive surgeries, in the form of 
spectacles, contact lens, corneal implant or shape modifica-
tion of cornea, are corrective approaches involving alteration 
10 of the gross focusing power of the eye to produce sharper 
retinal images. They do not eliminate or deal with the cause of 
the disorders, but are just prosthetic. 
The existing optical treatments to retard the progression of 
myopia by relieving the eye's accommodation during near 
15 visual tasks are recently shown to be clinically ineffective. 
As used herein, the term "defocus" refers to the shift of the 
optical images to a point behind or in front of the retina. The 
human eye has a feedback mechanism that regulates the 20 
growth of the eye to achieve an optimal balance between the 
size/length of the eye and the focal length of the optical 
elements of the eye. This feedback mechanism is called 
emmetropization. 
Examples of those treatments include bi-focal addition 
lenses, multi-focal progressive addition lenses and their 
derivatives, and spherical aberration manipulations. 
SUMMARY OF THE INVENTION 
The present invention is directed to a method for treating 
progression of a refractive disorder in a human eye. Particu-
larly, the present invention provides methods for counteract-
Myopia and hyperopia are common refractive disorders of 
human eyes. They are generally described as an imbalance 
between the focusing power of optical elements of the eye and 
the size/length of the eye. Focus of a myopic eye lies in front 
of the retina of the eye, while focus of a hyperopic eye lies 
behind the retina of the eye. It is generally accepted that these 
disorders are results of inaccurate axial growth during post-
natal development of the eyes. In other words, myopia typi-
cally develops when the size/length of the eye grows to 
exceed the focal length of the optical elements of the eye, 
while hyperopia typically develops when the size/length of 
the eye grows to be shorter than the focal length of the optical 
elements of the eye. 
25 ing the development of myopia by enhancing myopic defo-
cus. The present invention also provides methods for 
counteracting the development of hyperopia by enhancing 
hyperopic defocus. The apparatuses used in practice of the 
present invention alter the defocus equilibrium of the eye to 
30 influence axial eye growth in a direction towards emmetropia. 
35 
Referring to FIG. 1, an optical image 12 is formed in front 
According to a general aspect of the present invention, the 
method for treating progression of a refractive disorder in a 
human eye includes producing a first image on a retina of the 
human eye and producing a second image to generate a defo-
cus. 
According to one aspect of the present invention, the 
method for treating progression of a refractive disorder in a 
human eye includes providing a Fresnel lens having primary 
optical zones and secondary optical zones. The primary opti-
cal zones include a primary refractive power, and secondary 
optical zone includes at least one secondary refractive power. 
The method also includes correcting the refractive disorder 
with the primary refractive power and generating at least one 
of the retina in the case of myopia. Defocus in this case is 
positive and called myopic defocus 13. The emmetropization 40 
mechanism operates to retard eye growth in size until the 
retina 11 coincides with the optical image 12 when the myo-
pic defocus 13 diminished. As a result, the eye becomes less 
myopic. 
Referring to FIG. 2, optical image 22 is formed behind the 
retina 21 in the case of hyperopia. Defocus in this form is 
negative and called hyperopic defocus 23. The emmetropiza-
tion mechanism operates to promote eye growth in size until 
the retina 21 coincides with the optical image 22 when the 
hyperopic defocus 23 diminished. As a result, the eye 50 
becomes less hyperopic. 
45 defocus with the secondary refractive power. 
Referring to FIG. 3, the natural major sources of defocus 
for a human eye come from accommodation lag and ambient 
defocus. The accommodation lag is generally projected by 
the object of interest 35 onto the center of the retina 31 or 55 
macula 34 along a visual axis 32. It usually ranges from 0.5 D 
to 1.0 D of hyperopic defocus 36 for a non-presbyope during 
near visual tasks, such as reading. Ambient defocus is pro-
jected by peripheral visual objects other than the object of 
interest 35. Since peripheral objects are usually positioned 60 
more distant than the object of interest 35, they usually pro-
ducemyopic defocus up to 3.0 D during near visual tasks. For 
example, peripheral object 37 produce myopic defocus 38 at 
periphery of retina 31. Habitually, the peripheral visual 
objects are seldom positioned closer than the object of inter- 65 
est 35. However, if they do like peripheral object 39, hyper-
opic defocus 33 will be produced. 
According to another aspect of the present invention, the 
method for treating progression of a refractive disorder in a 
human eye includes prescribing an optical system having a 
back layer and a partially transparent front layer. The method 
also includes producing a primary image of one of the front 
and back layers on a retina of the human eye and producing a 
secondary image of the other layer of the front and back layers 
to generate a defocus. 
According to yet another aspect of the present invention, 
the method for treating progression of a refractive disorder in 
a human eye includes providing a lens including a central 
optical zone having a primary optical power and at least one 
peripheral optical zone having a secondary optical power. The 
method also includes producing a primary image on a retina 
of the human eye with the first optical power and producing at 
least one secondary image with the second optical power to 
generate a defocus. 
According to yet another aspect of the present invention, 
the method for treating progression of a refractive disorder in 
a human eye includes prescribing an optical system having a 
central visual object and at least one peripheral visual object. 
The method also includes producing a first image of the 
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central visual object on a central retina of the human eye and 
producing a second image of the peripheral visual object to 
generate a defocus. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a schematic diagram showing the section of a 
myopic eye and the nature of myopic defocus. 
FIG. 2 is a schematic diagram showing the section of a 
hyperopic eye and the nature of hyperopic defocus. 
FIG. 3 is schematic diagram showing the section of an eye, 
illustrating the source and the formation of accommodation 
lag and ambient defocus. 
FIG. 4a is a cross-sectional view of a Fresnel type concen-
tric bi-focal or multi -focal lens used in practice of the present 
invention. 
FIG. 4b is a back view of the Fresnel type concentric 
bi-focal or multi-focal lens of FIG. 4a. 
FIG. 5a is a diagram of a myopic eye fitted with a concen-
tric bi-focallens in accordance with the present invention. 
FIG. 5b is a diagram of a myopic eye fitted with a concen-
tric multi-focal lens in accordance with the present invention. 
FIG. 6a is a diagram of a hyperopic eye fitted with a 
concentric bi -focal lens in accordance with the present inven-
4 
The artificial shift of the defocus equilibrium in the optical 
system of the eye may be introduced by any desired method, 
for example by spectacle lens, spectacle lens add-on, contact 
lens, corneal shape-modification, ocular implant or desig-
nated viewing system. It is preferred that the shift be intro-
duced together with the conventional correction so that nor-
mal vision can be maintained throughout the treatment. This 
means that a focused image must be maintained near the 
macula 34, while one or more defocused images are being 
10 introduced into the optical system of the eye. 
A treatment method in accordance with the present inven-
tion introduces at least a defocused image and a focused 
image in a superimposed manner. The defocused and focused 
images can be introduced simultaneously, for example, by a 
15 concentric Fresnel type bi-focal or multi-focal lens as shown 
in FIGS. 4-6, diffractive multi -focal lens and their derivatives, 
or an optical system as shown in FIG. 7. 
Referring now FIGS. 4a and 4b, there shown is the Fresnel 
concentric bi -focal or multi -focal lens having alternating con-
20 centric optic zones 41 and 42 of at least two refractive powers 
used in practice of the present invention. A common way to 
manufacture the Fresnel concentric bi-focallens is to make 
one of the surfaces with two radius of curvature. For example, 
~ ~ 
the zone 42 with a shorter radius of curvature (i.e. more 
curved) than the other zone 41 with a longer radius of curva-
ture (i.e. flatter) exhibits a more negative refractive power. FIG. 6b is a diagram of a hyperopic eye fitted with a 
concentric multi-focal lens in accordance with the present 
invention. 
FIG. 7a is a diagram of a myopic eye fitted with an optical 
system having of a semi-transparent front layer and a non-
transparent back layer in accordance with the present inven-
tion. 
FIG. 7b is a diagram of a hyperopic eye fitted with an 
optical system having a non-transparent back layer and a 
semi-transparent front layer in accordance with the present 
invention. 
FIG. Sa is a cross-sectional view of a central-peripheral 
multi-focal lens used in practice of the present invention. 
FI G. Sb is a back view of the central-peripheral multi -focal 
lens of FIG. Sa. 
FIG. 9 is a diagram of a myopic eye fitted with the central-
peripheral multi-focal lens of FIG. Sa and FIG. Sb in accor-
dance with the present invention. 
FIG. 10 is a diagram of a hyperopic eye fitted with the 
central-peripheral multi-focal lens of FIG. Sa and FIG. Sb in 
accordance with the present invention. 
FIG. 11a is a diagram of a myopic eye fitted with an optical 
system having peripheral visual objects positioned closer 
than a central visual object in accordance with the present 
invention. 
FIG. 11b is a diagram of a hyperopic eye fitted with an 
optical system having peripheral visual objects positioned 
closer than a central visual object in accordance with the 
present invention. 
DETAILED DESCRIPTION OF THE INVENTION 
The present invention is directed to a method for treating 
progression of a refractive disorder in a human eye. Particu-
larly, the present invention provides a method for counteract-
ing the development of myopia by enhancing myopic defo-
cus. The present invention also provides a method for 
counteracting the development of hyperopia by enhancing of 
hyperopic defocus. The apparatuses used in practice of the 
present invention alter the defocus equilibrium of the eye to 
influence axial eye growth in a direction towards emmetropia. 
The zone with a more negative power 44 and the zone with a 
less negative power 43 alternate in a concentric manner. As a 
result, paraxial light rays and peripheral light rays share two 
30 common focal points. 
FIG. 5a shows a myopic eye fitted with a Fresnel type 
concentric bi-focallens 50 having a primary refractive power 
correcting the myopia and a secondary power to introduce 
myopic defocus in accordance with the present invention. 
35 Light rays 51 entering the optical zones having the primary 
power are focused on the retina 52, producing a sharp image 
of a visual object. At the same time, other light rays 53 
entering the optical zones having the secondary power are 
focused at a point 54 in front of the retina 52, producing the 
40 myopic defocus 55. When a myopic patient uses the lens 50 to 
view an object, the myopic defocus 55 prevents the eye from 
growing or elongating. Consequently, myopic progression in 
the myopic eye is slowed, stopped or reversed. 
FIG. 6a shows a hyperopic eye fitted with a Fresnel type 
45 concentric bi-focallens 60 having a primary refractive power 
to correct the hyperopia and a secondary power to introduce 
hyperopic defocus. Light rays 61 entering the optical zones 
having the primary power are focused onto the retina 62, 
producing a sharp image of a visual object. Simultaneously, 
50 other light rays 63 entering the optical zones having the 
secondary power are focused at a point 64 behind the retina 
62, producing the hyperopic defocus 65. When a hyperopic 
patient uses the lens 60 to view an object, the hyperopic 
defocus 65 promotes the eye in growing or elongating. Con-
55 sequently, myopic progression in the hyperopic eye is 
increased or induced, and hyperopia is reduced. 
A Fresnel type of concentric multi-focal lens is a derivative 
of the Fresnel type concentric bi-focallens. It has alternating 
concentric optic zones of more than two refractive powers. 
60 The primary refractive power corrects the refractive error, 
while the multiple secondary powers introduce optical defo-
cus for treatment. This can be achieved by a minor variation 
on the radius of curvature of the secondary optical zones. 
FIG. 5b shows a myopic eye fitted with a Fresnel type 
65 concentric multi-focal lens 56 in accordance with the present 
invention. Light rays 51 entering the optical zones having the 
primary power are focused on the retina 52, producing a sharp 
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image of a visual object. At the same time, other light rays 53 
entering the optical zones having the secondary powers are 
focused at points 57 in front of the retina 52, producing 
multiple myopic defocus 58 of various amplitudes. When a 
myopic patient uses the lens 56 to view an object, the myopic 
defocus 58 prevent the eye from growing or elongating. Con-
sequently, myopic progression in the myopic eye is slowed, 
stopped or reversed. 
FIG. 6b shows a hyperopic eye fitted with a Fresnel type 
concentric multi-focal lens 66. Light rays 61 entering the 10 
optical zones having the primary power are focused onto the 
retina 62, producing a sharp image of a visual object. Simul-
taneously, other light rays 63 entering the optical zones hav-
ing the secondary powers are focused at points 67 behind the 
retina 62, producing multiple hyperopic defocus 68 of various 15 
amplitudes. When a hyperopic patient uses the lens 66 to view 
6 
concentric mauner, with the refractive power decreasing from 
the central towards the peripheral across the lens. The transi-
tion can be subtle or progressive, depending on the manufac-
turing process. 
FIG. 9 shows a myopic eye fitted with a negative central-
peripheral multi-focal lens, which has a primary central 
refractive power correcting the myopia and a secondary 
peripheral refractive power to introduce myopic defocus, in 
accordance with the present invention. Light rays entering the 
central zone of the lens from a central visual objects 91 are 
focused onto the central retina, producing a corresponding 
central sharp image 92. Simultaneously, light rays entering 
the peripheral zone of the lens from the peripheral visual 
objects 93 are focused at points in front of the peripheral 
retina, producing the peripheral myopic defocus 94 required 
for the treatment effect for myopia. When a myopic patient 
uses the lens to view the visual objects 91 and 93, the myopic 
defocus 94 prevents the eye from growing or elongating. 
Consequently, myopic progression in the myopic eye is 
an object, the hyperopic defocus 68 promotes the eye in 
growing or elongating. Consequently, myopic progression in 
the hyperopic eye is increased or induced, and hyperopia is 
reduced. 20 slowed, stopped or reversed. 
FIG. 7a shows a myopic eye fitted with an optical system 
having a primary semi-transparent front layer 71 and a sec-
ondary non-transparent back layer 73 in accordance with the 
present invention. The front layer 71 matches the focal point 
of the eye, producing a sharp image 72 on the retina. At the 25 
same time, the back layer 73 produces an image 74 in front of 
the retina causing a myopic defocus 75 superimposed on the 
sharp image 72. When a myopic patient uses this optical 
system, the myopic defocus 75 prevents the eye from growing 
or elongating. Consequently, myopic progression in the myo- 30 
pic eye is slowed, stopped or reversed. 
FI G. 7 b shows a hyperopic eye fitted with an optical system 
having a primary non-transparent back layer 76 and a second-
ary semi-transparent front layer 78 in accordance with the 
present invention. The back layer 76 matches the focal point 35 
of the eye, producing a sharp image 77. In the same time, the 
front layer 78 produces an image 79 behind the retina causing 
a hyperopic defocus 80 superimposed on the sharp image 77. 
When a hyperopic patient uses this optical system, the hyper-
opic defocus 80 promotes the eye in growing or elongating. 40 
Consequently, myopic progression in the hyperopic eye is 
increased or induced, and hyperopia is reduced. 
FIG. 10 shows a hyperopic eye fitted with a positive cen-
tral-peripheral multi-focal lens, which have a primary central 
refractive power correcting the hyperopia and a secondary 
peripheral refractive power to introduce hyperopic defocus, 
in accordance with the present invention. Light rays entering 
the central zone of the lens from the central visual objects 101 
are focused onto the central retina, producing a corresponding 
central sharp image 102. Simultaneously, light rays entering 
the peripheral zone of the lens from the peripheral visual 
o bj ects 103 are focused at points behind the peripheral retina, 
producing the peripheral hyperopic defocus 104 required for 
the treatment effect for hyperopia. When a hyperopic patient 
uses this optical system, the hyperopic defocus 104 promotes 
the eye in growing or elongating. Consequently, myopic pro-
gression in the hyperopic eye is increased or induced, and 
hyperopia is reduced. 
FIG. 11a shows a myopic eye fitted with a pre-designed 
visual environment or an optical system, which has peripheral 
visual objects 113 positioned far away from the eye compared 
with the central visual object 111, in accordance with the 
present invention. Light rays from the central object 111, as 
directed by basic optics and the fixation reflex of the eye, are 
focused onto the central retina, producing a corresponding 
central sharp image 112. Simultaneously, light rays from 
peripheral visual objects 113 are focused at points in front of 
the peripheral retina, producing peripheral myopic defocus 
114 required for the treatment of myopia. When a myopic 
patient uses this optical system, the myopic defocus 114 
prevents the eye from growing or elongating. Consequently, 
To improve the visual performance produced by the treat-
ment methods and to avoid the user from mixing up his or her 
primary and secondary optical components, the optical qual- 45 
ity of the retinal image produced by the primary components 
can be strengthened over the image produced by the second-
ary components. This can be achieved by manipulating the 
area ratio between the different zones of the Fresnel lenses 
and manipulating the transmission proportion of the semi-
transparent layers. 
50 myopic progression in the myopic eye is slowed, stopped or 
reversed. 
An alternative method in accordance with the present 
invention introduces defocused image at peripheral retina 
only and keeps focused image at central retina. People habitu-
ally maintain a sharp image at central retina by a voluntary 
fixation reflex. Accordingly, the way to simultaneously 
present two images is the introduction of the defocus image at 
peripheral retina through the use of a central-peripheral 
multi-focal lens as shown in FIGS. 8-10 and a optical system 
as shown in FIG. 11. 
As shown in FIGS. 8a and 8b, the central-peripheral multi-
focal lens includes concentric optical zones of two or more 
optical powers. One way to manufacture this kind oflens is to 
generate the zones with materials of different refractive 
index. The central zone 81, which has a higher refractive 
index than the peripheral zone 82, exhibits higher refractive 
power. The two zones 81 and 82 are positioned in a generally 
FIG. 11b shows a hyperopic eye fitted with a pre-designed 
visual environment or an optical system, which has peripheral 
visual objects 117 positioned close to the eye compared with 
55 the central visual object 115. Light rays from the central 
object 115, as directed by basic optics and the fixation reflex 
of the eye, are focused onto the central retina producing a 
corresponding central sharp image 116. Simultaneously, light 
rays from peripheral visual objects 117 are focused at points 
60 behind the peripheral retina, producing peripheral hyperopic 
defocus 118 required for the treatment of hyperopia. When a 
hyperopic patient uses this optical system, the hyperopic 
defocus 118 promotes the eye in growing or elongating. Con-
sequently, myopic progression in the hyperopic eye is 
65 increased or induced, and hyperopia is reduced. 
Although the present invention has particular applications 
in curing and preventing the progression of refractive disor-
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ders of the eye such as myopia and hyperopia, it is to be 
understood that the invention could be used in other applica-
tions such as the prevention of pathological myopic degen-
eration of the eye. 
Although the present invention has been described with 
reference to preferred methods, workers skilled in the art will 
recognize that changes may be made in form and detail with-
out departing from the spirit and scope of the invention. In 
addition, the invention is not to be taken as limited to all of the 
details thereof as modifications and variations thereof may be 10 
made without departing from the spirit or scope of the inven-
tion. 
We claim: 
1. A method for retarding the progression of myopia or 
hyperopia in a human eye, the method comprising: 15 
(a) providing a Fresnel concentric multi-focal lens com-
prising primary optical zones having a primary refrac-
tive power and secondary optical zones having at least 
one secondary refractive power; and 
(b) correcting the myopia or hyperopia with the primary 20 
refractive power and generating at least one defocus 
with the secondary refractive power, 
wherein the primary optical zones enable near and distant 
objects to be viewed; and the secondary optical zones gener-
ate myopic defocus to retard myopia or generate hyperopic 25 
defocus to retard hyperopia. 
8 
2. The method of claim 1, wherein: 
the step (b) comprises focusing a first stream oflight rays of 
an object onto a retina of the human eye through the 
primary optical zones to correct the myopia and focus-
ing a second stream oflight rays of the object in front of 
the retina through the secondary optical zones to gener-
ate at least one myopic defocus. 
3. The method of claim 1, wherein: 
the step (b) comprises focusing a primary stream of light 
rays of an object onto a retina of the human eye through 
the first optical zones to correct the hyperopia and focus-
ing a second stream oflight rays of the object behind the 
retina through the secondary optical zones to generate at 
least one hyperopic defocus. 
4. The method of claim 1, wherein the step (a) comprises 
prescribing a Fresnel concentric bi-focal lens to produce a 
defocus in step (b). 
5. The method of claim 1, wherein the step (a) comprises 
providing a Fresnel concentric multi-focal lens producing 
two or more defocuses in step (b). 
6. The method of claim 1, wherein the Fresnel concentric 
multi-focal lens is a concentric bi-focallens. 
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